NEW DELHI, 12 DEC: The government will take steps to check import of bulk drugs from China, which is dumping the harmaceutical ingredients in the country, Union minister said on Saturday.
Minister of state for fertilisers Hansraj Gangaram Ahir said there is huge scope for growth of pharma sector in India and the government believes in ‘Make in India’ principle. He was speaking at the National Pharmaceuticals Conclave organised by CII here.
“China is a challenge in front of us. We are aware that there is need for changes in policy… It is dumping bulk drugs here. We will
discuss and take necessary steps to check the imports of bulk drugs from China,” Mr Ahir added.
The minister also advocated for higher coordination between research institutes and industry adding: “Our students can challenge anyone in the world and thus we can be the leading manufacturers.” A bulk drug or active pharmaceutical ingredient adds therapeutic
effect to medicine.
Earlier, Union fertilisers minister Ananth Kumar had said that India is largely dependent on China for imports of drug ingredients of 12 essential drugs which are in the National List of Essential Medicines (NLEM).
Mr Kumar had added that a Committee of Secretaries had already been constituted under the chairmanship of secretary, department of health research to study and identify the active pharmaceutical ingredients (APIs) of critical importance.
The government had decided to work out a package of interventions and concessions required to build domestic production capabilities and examine the cost implication, Mr Kumar added.